Skip to main content

Cigna vs Elevance Health: Revenue, Profit and Business Model

Cigna had $274.9B of annual revenue in FY2025. Elevance Health had $199.1B of annual revenue in FY2025.

Latest financial snapshot

Cigna

Latest annual revenue
$274.9B (FY2025)
Net income
Unavailable here
Net margin
—
Revenue growth
+23.9% a year, FY2016–FY2025

Elevance Health

Latest annual revenue
$199.1B (FY2025)
Net income
Unavailable here
Net margin
—
Revenue growth
+9.9% a year, FY2016–FY2025

Financial summary

Cigna

Revenue grew from $160.4 billion in 2020 to $274.9 billion in 2025, largely from Evernorth pharmacy volume, specialty drugs and new PBM clients. 2025 shareholders' net income was $6.0 billion ($22.18 per share), up from $3.4 billion in 2024, when results included a $2.7 billion after-tax loss on the VillageMD investment. Adjusted income from operations was $8.0 billion ($29.84 per share) in 2025. In the first half of 2026 Cigna reported $140.2 billion in revenue and $3.3 billion in shareholders' net income, and it raised 2026 adjusted EPS guidance to at least $30.45. The quarterly dividend was raised to $1.56 per share in February 2026.

Elevance Health

Revenue rose from $171.3B in 2023 to $177.0B in 2024 and $199.1B in 2025, helped by premium-rate increases, acquisitions and Medicare Advantage growth that offset Medicaid attrition. Net income was $5.662B in 2025 on operating income of $7.199B. Growth slowed in 2026 as the company deliberately shrank unprofitable Medicaid, Medicare Advantage and employer risk business: operating revenue was $49.5B in Q1 2026 and $49.8B in Q2 2026. In July 2026 Elevance raised full-year guidance to at least $20.10 GAAP diluted EPS and at least $27.00 adjusted EPS, with operating cash flow of at least $6.0B, and paid a $1.72 quarterly dividend. Elevance Health (formerly Anthem) is a massive American health insurance provider, maintaining a staggering market valuation generally exceeding $120 billion.

Revenue and profit by year

Cigna

Cigna revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025$274.9B——+11.2%Source
FY2024$247.1B——+26.6%Source
FY2023$195.3B——+8.2%Source
FY2022$180.5B——+3.7%Source
FY2021$174.1B——+8.5%Source
FY2020$160.4B——+4.5%Source
FY2019$153.6B——+215.7%Source
FY2018$48.6B——+16.4%Source
FY2017$41.8B——+4.9%Source
FY2016$39.8B———Source
Full Cigna financials

Elevance Health

Elevance Health revenue, net income, margin and growth by fiscal year
YearRevenueNet incomeMarginGrowthSource
FY2025$199.1B——+12.5%Source
FY2024$177B——+3.3%Source
FY2023$171.3B——+9.4%Source
FY2022$156.6B$5.9B3.8%+13.0%Source
FY2021$138.6B$6.2B4.4%+13.8%Source
FY2020$121.9B$4.6B3.8%+16.9%Source
FY2019$104.2B$4.8B4.6%+13.1%Source
FY2018$92.1B$3.8B4.1%+2.3%Source
FY2017$90B$3.8B4.3%+6.1%Source
FY2016$84.9B$2.5B2.9%—Source
Full Elevance Health financials

Where the revenue comes from

Cigna

  • Evernorth Health Services

    Majority of revenue

    Pharmacy benefit services, home delivery and Accredo specialty pharmacy dispensing, plus eviCore and MDLive care services.

  • Cigna Healthcare (U.S.)

    Second-largest

    Premiums from insured employer and individual plans and stop-loss, plus administrative fees from self-funded employers.

  • International Health

    Smaller share

    Health benefits for multinational employers and globally mobile individuals.

Elevance Health

  • Health Benefits

    About 83% of FY2025 revenue (premiums)

    Commercial, Medicare, Medicaid, BlueCard, FEP, and other insured or administrative health-plan products.

  • CarelonRx

    Pharmacy services

    Pharmacy benefit management and related pharmacy services integrated with Elevance's health-plan base and external customers.

  • Carelon Services

    Health services

    Care delivery, behavioral health, analytics, and other services designed to manage care and cost.

  • Investment Income and Other

    Supplemental

    Investment income and other revenue streams tied to the insurance and services platform.

Business model and strategy

Cigna

How it makes money

Cigna makes money in two ways. Evernorth Health Services, the larger business by revenue, runs Express Scripts pharmacy benefit management, Accredo specialty pharmacy, home-delivery pharmacy, eviCore utilization management and MDLive virtual care; it earns dispensing margins, administrative and service fees, and purchasing economics on prescription drugs for health plans and employers.

Growth strategy

Cigna's growth plan centers on Evernorth: winning PBM clients with the rebate-free and transparent pricing models, growing Accredo specialty pharmacy and biosimilar programs, and selling services such as EncircleRx for GLP-1 cost management and Embarc Benefit Protection for gene therapies to other health plans and employers.

Competitive advantage

Cigna's edge is scale in pharmacy plus a capital-light medical business. Evernorth managed about 118 million pharmacy customers at June 30, 2026, giving it purchasing power with drug makers and pharmacies, and Accredo is one of the largest U.S. specialty pharmacies.

Cigna business model in full

Elevance Health

How it makes money

Elevance makes money in two ways. First, its Health Benefits segment collects premiums from employers, individuals and government programs and pays members' medical claims; profit depends on keeping the benefit expense ratio (89.7% in Q2 2026) below premium levels and on fees for administering self-funded employer plans.

Growth strategy

Elevance is pruning lower-margin business, such as exiting standalone Medicare Part D plans for 2026 and the D.C. Medicaid market, while investing in medical cost management, provider connectivity and Carelon. Recent deals that extend Carelon include BioPlus specialty pharmacy (2023), Kroger Specialty Pharmacy (2024) and CareBridge home-based care (reported at about $2.7B, 2024 to 2025).

Competitive advantage

Elevance's main edge is its Blue Cross Blue Shield licenses in 14 states, which give it dense local provider networks and strong brand recognition with employers, plus access to the national BlueCard network. Owning CarelonRx and Carelon Services lets it keep pharmacy and care-management revenue that rivals without those assets pay to third parties.

Elevance Health business model in full

Questions about Cigna vs Elevance Health

Which company has higher revenue — The Cigna Group or Elevance Health, Inc.?

The Cigna Group had $274.9B (FY2025), while Elevance Health, Inc. had $199.1B (FY2025). By latest annual revenue, The Cigna Group is the larger business, with Elevance Health, Inc. showing a smaller revenue base.

What is the market cap of The Cigna Group vs Elevance Health, Inc.?

The Cigna Group's market capitalisation stands at $71.9B, while Elevance Health, Inc.'s is $80.0B. Elevance Health, Inc. carries the higher market valuation, reflecting investors' expectations of its future earnings power relative to The Cigna Group.

How does revenue per employee compare for The Cigna Group and Elevance Health, Inc.?

The Cigna Group has $4.06M / employee in revenue per employee, while Elevance Health, Inc. has $2.05M / employee. Headcounts may use different dates, so the ratio alone does not establish which business operates more efficiently.

How do The Cigna Group and Elevance Health, Inc. make money?

The Cigna Group and Elevance Health, Inc. generate revenue in fundamentally different ways. The Cigna Group: Cigna makes money in two ways. Elevance Health, Inc.: Elevance makes money in two ways.

Which company is valued higher relative to revenue — The Cigna Group or Elevance Health, Inc.?

On a price-to-sales (P/S) basis, The Cigna Group trades at 0.3x P/S and Elevance Health, Inc. at 0.4x P/S. Elevance Health, Inc. commands a higher revenue multiple, typically indicating that investors expect faster growth or higher future margins compared to The Cigna Group. A higher multiple is not inherently better — it may also signal that the stock is priced for perfection.

Is The Cigna Group bigger than Elevance Health, Inc.?

By last reported revenue, The Cigna Group ($274.9B (FY2025)) is the larger company compared to Elevance Health, Inc. ($199.1B (FY2025)). Revenue scale is one dimension of size — market capitalisation, employee count, and geographic reach are also relevant depending on the context.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Cigna vs Elevance Health overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.